[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786 432 9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 46, "title": "CEO & Chairman", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 626193, "exercisedValue": 0, "unexercisedValue": 113700}, {"maxAge": 1, "name": "Mr. Alan  Weichselbaum CPA, M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.35, "open": 1.33, "dayLow": 1.33, "dayHigh": 1.425, "regularMarketPreviousClose": 1.35, "regularMarketOpen": 1.33, "regularMarketDayLow": 1.33, "regularMarketDayHigh": 1.425, "payoutRatio": 0.0, "beta": 1.749, "forwardPE": -2.8367345, "volume": 274242, "regularMarketVolume": 274242, "averageVolume": 3195326, "averageVolume10days": 298890, "averageDailyVolume10Day": 298890, "bid": 1.35, "ask": 1.44, "bidSize": 1, "askSize": 1, "marketCap": 58207760, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 2.45, "allTimeHigh": 7.98, "allTimeLow": 0.51, "fiftyDayAverage": 1.4237, "twoHundredDayAverage": 1.295215, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 50671856, "profitMargins": 0.0, "floatShares": 27933863, "sharesOutstanding": 41876087, "sharesShort": 516658, "sharesShortPriorMonth": 247361, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0248, "heldPercentInsiders": 0.16653, "heldPercentInstitutions": 0.032479998, "shortRatio": 0.07, "shortPercentOfFloat": 0.0326, "impliedSharesOutstanding": 41876087, "bookValue": 0.191, "priceToBook": 7.277487, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -28415680, "trailingEps": -1.6, "forwardEps": -0.49, "52WeekChange": 0.030534387, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 1.39, "targetHighPrice": 17.75, "targetLowPrice": 3.0, "targetMeanPrice": 10.375, "targetMedianPrice": 10.375, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 7535905, "totalCashPerShare": 0.18, "totalDebt": 0, "quickRatio": 89.792, "currentRatio": 90.53, "returnOnAssets": -0.74644995, "returnOnEquity": -1.2332599, "freeCashflow": -2723576, "operatingCashflow": -5331662, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 1.39, "marketState": "CLOSED", "longName": "MIRA Pharmaceuticals, Inc.", "shortName": "MIRA Pharmaceuticals, Inc.", "fiftyDayAverageChange": -0.03369999, "fiftyDayAverageChangePercent": -0.02367071, "twoHundredDayAverageChange": 0.094784975, "twoHundredDayAverageChangePercent": 0.073180884, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1763773055, "regularMarketTime": 1763758801, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.96296, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1691069400000, "postMarketChangePercent": 0.0071954383, "postMarketPrice": 1.3901, "postMarketChange": 0.000100016594, "regularMarketChange": 0.04, "regularMarketDayRange": "1.33 - 1.425", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3195326, "fiftyTwoWeekLowChange": 0.65999997, "fiftyTwoWeekLowChangePercent": 0.90410954, "fiftyTwoWeekRange": "0.73 - 2.45", "fiftyTwoWeekHighChange": -1.0600001, "fiftyTwoWeekHighChangePercent": -0.43265307, "fiftyTwoWeekChangePercent": 3.0534387, "epsTrailingTwelveMonths": -1.6, "epsForward": -0.49, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]